TrovaGene Inc.

TrovaGene Inc.
Stock Exchange NASDAQ Stock Market
EPS
$8.49
Market Cap
$13.06 M
Shares Outstanding
5.42 M
Public Float
3.99 M

Profile

Address
11055 Flintkote Avenue
San Diego California 92121
United States
Employees -
Website http://www.trovagene.com
Updated 07/08/2019
Trovagene, Inc. is a clinical-stage, precision medicine oncology therapeutics company. Its focuses on developing PCM-075, is a Polo-like Kinase 1 (PLK1) selective adenosine triphosphate (ATP) competitive inhibitor. The company was founded by Gabriel M.

Financials

View All

Thomas H. Adams
Chairman & Chief Executive Officer
Athena Countouriotis
Independent Director